Back to Search
Start Over
Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a patient with psoriasis. Comment on 'Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab'
- Source :
- Clinical & Experimental Dermatology; Jun2023, Vol. 48 Issue 6, p701-703, 3p, 2 Color Photographs
- Publication Year :
- 2023
-
Abstract
- Comment on 'Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab' Google Scholar Crossref Search ADS PubMed WorldCat 8 Berman HS, Villa NM, Shi VY, Hsiao JL. Guselkumab in the treatment of concomitant hidradenitis suppurativa, psoriasis, and Crohn's disease. Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a patient with psoriasis. [Extracted from the article]
Details
- Language :
- English
- ISSN :
- 03076938
- Volume :
- 48
- Issue :
- 6
- Database :
- Complementary Index
- Journal :
- Clinical & Experimental Dermatology
- Publication Type :
- Academic Journal
- Accession number :
- 164984220
- Full Text :
- https://doi.org/10.1093/ced/llad082